Product Reports Resources Pricing Login Book a demo

MedGenome Labs

Biotech & Life Sciences · Foster City, United States · Founded 2013

A genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome

Valuation $100–500M
Revenue $50–100M
Headcount 1–2k
Unlock exact values This page shows ranges. Dealroom has the exact numbers for MedGenome Labs and the history behind them.
Power Law Colt$25–100M revenue

Talent graph

MedGenome Labs's talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

14 investors on MedGenome Labs's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 5 investors entered at this stage
Papillon Capital
Vidinovo
Emerge Ventures
Singapore
InnoVen Capital
Series B+ 9 investors entered at this stage
HDFC ERGO General Insurance Company Limited
Sofina
Novo Holdings
Sequoia
LeapFrog Investments
Novo Seeds
Maj Invest
Zodius Capital
International Finance Corporation

Global footprint

Where MedGenome Labs has talent and traffic

Workforce by country
🇺🇸 United States · Foster City HQ
Book a demo for the full country breakdown
Web traffic by country
4.3K monthly visits
across markets
🇺🇸 United States83.7%
🇳🇿 New Zealand16.3%
🇮🇳 India0%
Top 3 markets shown

Capital deployed

MedGenome Labs's 5 investments and acquisitions.

Every disclosed deal where MedGenome Labs appeared as a backer or acquirer, 2016–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

5 deals across MedGenome Labs's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        MedGenome Labs's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        5 of 5 deals

        Market sentiment

        What the market is saying about MedGenome Labs

        An AI-synthesized read of the highest-engagement posts about MedGenome Labs on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See MedGenome Labs on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles